Search results
Results from the WOW.Com Content Network
The Patient Health Questionnaire 2 item (PHQ-2) is an ultra-brief screening instrument containing the first two questions from the PHQ-9. [ 8 ] : 3 Two screening questions to assess the presence of a depressed mood and a loss of interest or pleasure in routine activities , and a positive response to either question indicates further testing is ...
[1] [2] [3] The PHQ-9 is a component of the larger self-administered Patient Health Questionnaire (PHQ), but can be used as a stand-alone instrument. [4] The PHQ is part of Pfizer's larger suite of trademarked products, called the Primary Care Evaluation of Mental Disorders (PRIME-MD). [5] The PHQ-9 takes less than three minutes to complete.
The following diagnostic systems and rating scales are used in psychiatry and clinical psychology.This list is by no means exhaustive or complete. For instance, in the category of depression, there are over two dozen depression rating scales that have been developed in the past eighty years.
The Patient Health Questionnaire-2 (PHQ-2) is a shorter version of the PHQ-9 with two screening questions to assess the presence of a depressed mood and a loss of interest or pleasure in routine activities; a positive response to either question indicates further testing is required. [10]
The SSD-12 can be used in combination with the Patient Health Questionnaire-15 (PHQ-15). [9] and the Somatic Symptom Scale-8 (SSS-8) [10] to identify persons at risk for SSD. [2] Optimal combined cutpoints were ⩾9 for the PHQ-15 or SSS-8, and ⩾23 for the SSD-12 (sensitivity and specificity = 69% and 70%) [8]
The original study that proposed the GHQ was published in 1970 by David Goldberg and Dr. Blackwell. [9] This study was originally completed to validate the General Health Questionnaire as a reliable determinant of psychiatric health in general practice. [9] [10] [11] The GHQ was given to 3000 patients at a general medicine practice in London. [9]
The Youth Outcome Questionnaire is a collection of questions designed to collect data regarding the effectiveness of youth therapies. [1] The Y-OQ is a parent report measure of treatment progress for children and adolescents (ages 4–17) receiving mental health interventions.
PSYCHLOPS is a mental health outcome-measure tool used in primary care or community care settings and is self-completed. It measures mental health problems, quality of life, social functioning and wellbeing.